Charlotte I Stroes

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Charlotte I Stroes, Sandor Schokker, Mohammed Khurshed, Stephanie O van der Woude, Ron Aa Mathôt, Marije Slingerland, Judith de Vos-Geelen, Massimo Zucchetti, Cristina Matteo, Erik van Dijk, Bauke Ylstra, Victor Thijssen, Sarah Derks, Tesfay Godefa, Willemieke Dijksterhuis, Gerben E Breimer, Otto M van Delden, Rob Ha Verhoeven, Sybren L Meijer, Maarten F Bijlsma, Hanneke W M van Laarhoven
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT). Therapeutic advances in medical oncology 14 (2022)
Charlotte I Stroes, Sandor Schokker, Remco J Molenaar, Ron A A Mathot, Maarten F Bijlsma, Stephanie O van der Woude, João P Belo Pereira, Gerrit K J Hooijer, Rob H A Verhoeven, Annemieke Cats, Cecile Grootscholten, Johanna W van Sandick, Geert-Jan Creemers, Grard A P Nieuwenhuijzen, Nadia Haj Mohammad, Jelle P Ruurda, Sybren L Meijer, Maarten C C M Hulshof, Mark Ivo van Berge Henegouwen, Hanneke W M van Laarhoven
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX. Cancers 13 (4) (2021)

Charlotte I Stroes.css-eqlu8i{font-size:small;padding-left:4px;}